Psoriasis is a chronic skin disease that manifests itself mainly with skin symptoms (dryness, itching, scaly skin, abnormal ...

Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) and AnaptysBio, Inc. (Anaptys) (NASDAQ: ANAB) today announced an exclusive, global license agreement for the development and commercialization of imsidolimab ...

Vanda expects to immediately begin preparing BLA and MAA applications for the U.S. and EU.

Vanda Pharmaceuticals (VNDA) and AnaptysBio (ANAB) announced an exclusive, global license agreement for the development and commercialization ...

Vanda Pharmaceuticals (VNDA) and AnaptysBio (ANAB) announced an exclusive, global license agreement for the development and commercialization ...

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) and AnaptysBio, Inc. (Anaptys) (Nasdaq: ANAB) today announced an exclusive, ...

The following is a summary of “Global Delphi consensus on treatment goals for generalised pustular psoriasis,” published in the January 2025 issue of Dermatology by Barker et al. Generalized pustular ...

Zasocitinib is under development for the treatment of moderate to severe plaque psoriasis, psoriatic arthritis, generalized pustular psoriasis, erythrodermic psoriasis, inflammatory bowel disease (IBD ...

Guttate psoriasis mainly affects the trunk and proximal extremities, but may be generalized in distribution. Lesions may affect the face, ears, and scalp, but the palms and soles are rarely involved.

Secukinumab has demonstrated results of long-term safety and efficacy in the treatment of pediatric generalized pustular psoriasis (GPP), according to a recent study published in the Journal of ...

A few treatments are known to help clear psoriasis symptoms fast, such as Clobex spray, cyclosporine, and Humria. When choosing a psoriasis treatment, however, also consider other factors like side ...